Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis

about

Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis

Item

http://www.wikidata.org/entity/Q59126578

description

scientific article published on 14 November 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis

@en

Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis

@nl

type

Item

label

Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis

@en

Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis

@nl

prefLabel

Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis

@en

Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis

@nl

P1476

Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis

@en

P2093

Dong Soon Kim

http://www.w3.org/2001/XMLSchema#string

Hee-Young Yoon

http://www.w3.org/2001/XMLSchema#string

Jung Jin Hwang

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

Rapamycin and mTOR kinase inhibitors

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors

Standardisation of the measurement of lung volumes

Standardisation of the single-breath determination of carbon monoxide uptake in the lung

Standardisation of spirometry

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis

ATS statement: guidelines for the six-minute walk test.

mTORC2 is required for proliferation and survival of TSC2-null cells.

P2888

s13023-018-0946-8

P304

204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13023-018-0946-8

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jin Woo Song

P577

2018-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1109900400

http://www.w3.org/2001/XMLSchema#string

P698

30428897

http://www.w3.org/2001/XMLSchema#string

P932

6236936

http://www.w3.org/2001/XMLSchema#string